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Abstract: This study aimed for the synthesis of new heterocyclic compounds incorporating  
sulfamoyl moiety suitable for use as antimicrobial agents via a versatile, readily accessible 
N-[4-(aminosulfonyl)phenyl]-2-cyanoacetamide (3). The 2-pyridone derivatives were 
obtained via reaction of cyanoacetamide with acetylacetone or arylidenes malononitrile. 
Cycloaddition reaction of cyanoacetamide with salicyaldehyde furnished chromene 
derivatives. Diazotization of 3 with the desired diazonium chloride gave the hydrazone 
derivatives 13a–e. Also, the reactivity of the hydrazone towards hydrazine hydrate to give 
Pyrazole derivatives was studied. In addition, treatment of 3 with elemental sulfur and 
phenyl isothiocyanate or malononitrile furnished thiazole and thiophene derivatives 
respectively. Reaction of 3 with phenyl isothiocyanate and KOH in DMF afforded the 
intermediate salt 17 which reacted in situ with 3-(2-bromoacetyl)-2H-chromen-2-one  
and methyl iodide afforded the thiazole and ketene N,S-acetal derivatives respectively. 
Finally, reaction of 3 with carbon disulfide and 1,3-dibromopropane afforded the 
N-[4-(aminosulfonyl) phenyl]-2-cyano-2-(1,3-dithian-2-ylidene)acetamide product 22.  
All newly synthesized compounds were elucidated by considering the data of both elemental 
and spectral analysis. The compounds were evaluated for both their in vitro antibacterial and 
antifungal activities and showed promising results. 
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1. Introduction 
Cyanoacetamides and their related heterocyclic derivatives have generated a great deal of attention 
due to their interesting biological and therapeutic value; their pharmaceutical activities include: 
antimicrobial [1,2], antifungal [3], insulin releasing [4], carbonic anhydrase inhibitory [5], 
anti-inflammatory [6], and antitumor properties [7]. Some active sulfonamides as antibacterials are also 
known for their immunmodifying effects [8,9]. In addition, several thiazole derivatives possess 
important pharmacological activities and therefore they are useful materials in drug research.   
Over the past few decades, the literature has been enriched with progressive findings about the 
anticonvulsant activities of various substituted thiazole derivatives [10–14] that are of interest as 
potential neuroprotective agents [15,16]. Some 2-pyridones are also reported to possess antitumor [17], 
antibacterial [18] and other biological activities [19,20]. In view of these facts and as a continuation of 
our research program on the chemistry of butanamide [21,22], the present investigation aimed to 
synthesize and characterize newer hydrazones, pyridones, acrylamide, Pyrazole, thiadiazole, and 
thiophene incorporating sulfonamide moiety. It was found that N-[4-(aminosulfonyl)phenyl]- 
2-cyanoacetamide (3) is an excellent building block for the synthesis of the target objectives. 
2. Results and Discussion 
One reason of our interest in amines is related to the conversion possibility of their NH2 group to  
the NHCOCH2CN group, which leads to cyanoacetamide with further useful functionalization at   
this position [23,24]. Cyanoacetamide 3 was synthesized by cyanoacetylation of 1 with 
3,5-dimetyl-1-cyanoacetyl Pyrazole (2) [25] as previously described (Scheme 1). 
Scheme 1. Synthesis of cyanoacetamide 3. 
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Thus, the Knoevengel condensation of the cyanoacetamide 3 with aromatic aldehydes namely 
benzaldehyde,  p-anisaldehyde, and p-chlorobenzaldehyde furnished the corresponding arylidene 
derivatives 5a–c (Scheme 2). The IR spectrum of compound 5a, taken as a typical example of the  
series prepared, revealed absorption bands at 1680, 2220 and 3362 cm
−1 corresponding to carbonyl, 
nitrile and NH functions, respectively. Its 
1H-NMR spectrum showed signals at δ 8.32 and 10.70 Int. J. Mol. Sci. 2014, 15 1239 
 
(D2O-exchangeable) due to CH and NH protons in addition to two aromatic protons at δ 7.81–7.83.  
Its mass spectrum showed a molecular ion peak at m/z 327. Pyridin-2(1H)-ones 7a–c was obtained 
through the reaction of the arylidene derivatives 5a–c with malononitrile in dioxane containing 
piperidine as catalyst. One-pot reactions of the cyanoacetamide derivative 3 with malononitrile and the 
same aldehydes (1:1:1 molar ratio) at reflux temperature in the presence of piperidine afforded the 
2-pyridone derivatives 7a–c. Spectroscopic data as well as elemental analyses of the obtained products 
were in complete agreement with the assigned structures 7a–c. In addition, when the cyanoacetamide 3 
was reacted with acetylacetone in dioxane in the presence of a catalytic amount of triethylamine, the 
cyclocondensation reaction occurred and the 2-pyridinone derivatives 10 were smoothly afforded. It can 
be postulated that the reaction initially proceeds via a nucleophilic attack to form the Michael adduct 
which in turn cyclized and eliminated two water molecules, affording the final product (Scheme 2). 
Scheme 2. Synthesis of arylidene 5a–c and pyridones 7a–c and 10. 
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Similarly, cyclocondensation of cyanoacetamide 3 with salicyaldehyde in dioxane in the presence of 
a catalytic amount of piperidine afforded 2-iminochromene 11 in high yield. On the other hand, by 
interaction of 3 with salicyaldehyde in the presence of AcOH/AcONa, chromenone 12 was obtained in 
reasonably good yield. The structure of compound 12 was further confirmed through its synthesis upon Int. J. Mol. Sci. 2014, 15 1240 
 
hydrolysis of 11 with ethanolic HCl. (Scheme 3). The IR spectrum of the reaction product 11 revealed 
the disappearance of cyano absorption band and showed absorption bands at 1680, 3244 and 3318 cm
−1 
corresponding to carbonyl and two NH functions, respectively. Its 
1H-NMR spectrum showed   
two D2O-exchangeable signal at δ 9.29 and 13.11 due to two NH protons, in addition to an aromatic 
multiplet in the region 7.58–7.83. It mass spectrum showed a molecular ion peak at m/z 343 while 
1H-NMR spectrum of 12 showed one D2O-exchangeable signal at δ 10.88 due to one NH proton. 
Scheme 3. Synthesis of 2-imino-2H-chromene 11 and 2-oxo-2H-chromene 12. 
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Next, we studied the reactivity of the active methylene group present in compound 3 towards 
diazonium salts. Thus, cyanoacetamide 3 coupled with diazonium salts, derived from the appropriate 
aromatic amines (4-methylaniline, 4-methoxyaniline, aniline, 4-chloroaniline, and methyl anthranilate) 
in pyridine to afford the respective hydrazones 13a–e (Scheme 4). Analytical and spectral data of the 
latter reaction products are all consistent with the proposed structures. 
Scheme 4. Synthesis of hydrazones 13a–e and aminopyrazole 14a,b. 
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Further elucidation of the structure of 13a,b came from the reaction with hydrazine hydrate to furnish 
the Pyrazole products 14a,b. The structures of compounds 14a,b were confirmed based on elemental 
analysis and spectral data (see Experimental section). 
In view of the growing biological importance of thiazole derivatives, it was considered of interest to 
synthesize some new derivative of thiazole. Thus, the reaction of compound 3 with phenyl 
isothiocyanate and elemental sulfur gave the thiazole-2-thione derivative 15. The reaction of 
cyanoacetamide 3 with elemental sulfur and malononitrile gave the thiophene derivative 16 (Scheme 5). 
Analytical and spectral data of the products are in agreement with the proposed structure   
(see Experimental section). 
Scheme 5. Synthesis of aminothiazole 15 and diaminothiophene 16. 
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The reactivity of cyanoacetamide 3 towards isothiocyanate was investigated. Thus, when 3 was left to 
react with phenyl isothiocyanate in dimethylformamide, in the presence of potassium hydroxide, at room 
temperature, the corresponding potassium salt 17 was obtained. Heterocyclization of the intermediate 17 
with chloroacetone or 3-(2-bromoacetyl)-2H-chromen-2-one furnished in each case, one isolable 
product (as tested by TLC). Probably the reaction proceeds via nucleophilic displacement of the halogen 
atom to give an S-alkylated intermediate followed by loss of water of the latter intermediate to give 
thiazole derivatives 18 and 19 as the final products. The structures of the products 18 and 19 as well as 
the rejection of 18' were determined from spectroscopic and elemental analytical data. Analytical and 
spectral data of the product are in agreement with the proposed structure (see Experimental section). 
Furthermore, the non-isolated potassium salt was methylated by treatment with methyl iodide to afford 
the novel ketene N,S-acetal 20 (Scheme 6). The structure of the synthesized product was established on 
the basis of their elemental analysis and spectral data (see Experimental section). 
Stirring the cyanoacetamide 3 with carbon disulfide in the presence of potassium hydroxide   
in  N,N-dimethylformamide followed by cycloalkylation with 1,3-dibromopropane afforded 
N-[4-(amino-sulfonyl)phenyl]-2-cyano-2-(1,3-dithian-2-ylidene)acetamide (22) (Scheme 7). The   
IR spectra of compound 22 showed characteristic bands for NH, CH–aliphatic, C≡N and C=O groups. 
1H-NMR spectrum of compound 22 showed signals for dithiene moiety at δ 2.18 ppm (m, 2H,   
J = 6.80 Hz, CH2), 3.04 (t, 2H, J = 6.60 Hz, CH2), 3.19 (t, 2H, J = 6.60 Hz, CH2). Mass spectrum of 22 
showed a molecular ion peak at m/z: 355 with a base peak at m/z: 183 (100%). Int. J. Mol. Sci. 2014, 15 1242 
 
Scheme 6. Synthesis of thiazoles 18, 19 and acrylamide 20. 
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Scheme 7. Synthesis of 1,3-dithian-2-ylidene 22. 
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2.1. Screening for Antimicrobial Activity 
The newly synthesized compounds 5a, 5c, 7b, 7c, 10, 11, 13b, 14a, 15, 16, 18, 19 and 22 were 
evaluated for their in vitro antibacterial activity against Streptococcus pneumoniae (RCMB-010010) 
(SP) and Bacillis subtilis (RCMB-010067) (BS) as examples of Gram-positive bacteria and 
Pseudomonas aeruginosa (RCMB-010043) (PA) and Escherichia coli (RCMB-010052) (EC) as 
examples of Gram-negative bacteria. They were also evaluated for their in vitro antifungal activity 
against  Aspergillus fumigatus (RCMB-02568) (AF),  Syncephalastrum racemosum (RCMB-05922) 
(SR), Geotricum candidum (RCMB-05097) (GC) and Candida albicans (RCMB-05036) (CA) fungal 
strains. Inhibition zone diameter (IZD) in mm was used as criterion for the antimicrobial activity using 
the diffusion technique [26–28]. The fungicide Amphotericin B and the bactericides Ampicillin   
and Gentamicin were used as references to evaluate the potency of the tested compounds under the  
same conditions. The results are depicted in Table 1. As seen from the data present in Table 1, 
Streptococcus pneumoniae and Bacillis subtilis are sensitive to all tested compounds except compounds 
11 and 16; furthermore, Pseudomonas aeruginosa is sensitive to compounds 5a, 7c and 15, while 
Escherichia coli is sensitive to 5a, 7b, 7c, 10, 13b, 14a, 15, 18, 19 and 22 except compounds 11 and 16. 
All tested compounds except compound 16 exhibit antifungal activity against the three tested fungi 
species  Aspergillus fumigatus,  Syncephalastrum racemosum and Geotricum candidum. Also the 
Candida albicans strain is sensitive to compounds 5a, 5c, 7c, 10, 11. The high activity of 5a, 7c and 10 is 
attributed to the presence of pharmacological active arylidene moiety in compound 5a and pyridone ring 
in 7c and 10. The inactivity of compound 16 against the tested bacteria and fungi is due to the presence 
of a thiophene ring. 
Table 1. Antibacterial and antifungal activities of the synthesized compounds (5a, 5c, 7b, 
7c, 10, 11, 13b, 14a, 15, 16, 18, 19 and 22). 
Comp. 
Inhibition zone diameter (cm)
Gram (+)  Gram (−) Fungi 
Standard 
values 
(SP)  (BS) (PA)  (EC) (AF) (SR) (GC)  (CA) 
23.8 ± 0.2  32.4 ± 0.3  17.3 ± 0.1  19.9 ± 0.3  23.7 ± 0.2  19.7 ± 0.2  28.7 ± 0.2  25.4 ± 0.1 
5a  18.9 ± 0.44  21.7 ± 0.25  11.6 ± 0.19  15.4 ± 0.39  20.2 ± 0.55  16.3 ± 0.25  22.4 ± 0.58  19.6 ± 0.33 
5c  16.3 ± 0.55  18.3 ± 0.25  NA  NA  17.3 ± 0.44  12.6 ± 0.25  19.0 ± 0.58  16.9 ± 0.25 
7b  16.9 ± 0.58  18.2 ± 0.44  NA  11.9 ± 0.63  15.7 ± 0.33  13.8 ± 0.25  18.3 ± 0.34  NA 
7c  18.3 ± 0.25  22.6 ± 0.44  13.1 ± 0.32  20.3 ± 0.09  20.6 ± 0.58  16.7 ± 0.33  22.4 ± 0.36  17.6 ± 0.58 
10  16.7 ± 0.36  19.2 ± 0.27  NA  13.6 ± 0.36  16.8 ± 0.39  13.4 ± 0.58  19.6 ± 0.19  15.9 ± 0.44 
11  NA NA NA  NA  15.7  ±  0.36  11.2 ± 0.33  17.3 ± 0.44  13.3 ± 0.36 
13b  12.3 ± 0.58  12.7 ± 0.37  NA  8.5 ± 0.37  17.6 ± 0.58  15.4 ± 0.25  12.6 ± 0.38  NA 
14a  17.5 ± 0.44  19.8 ± 0.63  NA  18.9 ± 0.25  15.3 ± 0.55  13.4 ± 0.35  11.5 ± 0.58  NA 
15  15.0 ± 0.43  17.4 ± 0.53  12.3 ± 0.25  17.8 ± 0.03  11.3 ± 0.34  12.1 ± 0.25  15.3 ± 0.38  NA 
16  NA  NA  NA NA NA NA NA  NA 
18  16.9 ± 0.58  18.2 ± 0.44  NA  11.9 ± 0.63  16.2 ± 0.36  15.0 ± 0.44  17.6 ± 0.58  NA 
19  12.9 ± 0.63  13.2 ± 0.58  NA  10.8 ± 0.44  18.7 ± 0.36  16.9 ± 0.27  13.4 ± 0.65  NA 
22  12.3 ± 0.58  12.7 ± 0.37  NA  10.8 ± 0.44  17.6 ± 0.58  15.4 ± 0.25  12.6 ± 0.38  NA 
Data are expressed in the form of mean ± SD. Mean zone of inhibition in mm ± standard deviation beyond well diameter; (6 mm) produced 
on a range of environmental and clinically pathogenic microorganism using (5 mg/mL) concentration of tested sample (100 µL was tested). Int. J. Mol. Sci. 2014, 15 1244 
 
3. Experimental Section 
3.1. General Experimental Procedures 
All melting points were measured on an Electrothermal Gallenkamp apparatus (Weiss-Gallenkamp, 
London, UK). The infrared spectra were recorded in potassium bromide discs on a Pye Unicam SP3300 
and Shimadzo FT IR 8101 PC infrared spectrophotometers (Pye Unicam Ltd., Cambridge, UK and 
Shimadzu, Tokyo, Japan, respectively). The 
1H-NMR spectra were recorded on a Varian Mercury 
VXR-300 spectrometer (300 MHz, Vernon Hills, IL, USA). The mass spectra were recorded on a 
GCMS-Q1000-EX Shimadzu and GCMS 5988-A HP spectrometers (Kyoto, Japan), the ionizing voltage 
was 70 eV. Elemental analyses were carried out at the Micro-analytical Center of Cairo University, Giza, 
Egypt. The biological evaluation of the products was carried out in the Medical Mycology Laboratory of 
the Regional Center for Mycology and Biotechnology of Al-Azhar University, Cairo, Egypt. The 
starting material 3-(2-bromoacetyl)-2H-chromen-2-one was prepared as previously reported in the 
literature [29,30]. 
3.2. Synthetic Procedures 
3.2.1. 2-Cyano-N-(4-sulfamoylphenyl)acetamide (3) 
A mixture of 1 (3.44 g, 20 mmol) and 3,5-dimetyl-1-cyanoacetyl Pyrazole (2) (3.26 g, 20 mmol) in 
dioxane (20 mL) was refluxed for 3 h. The reaction mixture was poured into crushed ice. The resulting 
precipitate was filtrated off, dried, and crystallized from DMF/MeOH (1:3) to give 3; Yield (70%), mp 
248 °C (from DMF/MeOH) (lit. mp 230 °C) [31]; IR (KBr) νmax: 3337, 3236, 3102 (NH, NH2), 2269 
(C≡N), 1687 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.96 (s, 2H, CH2), 7.29 (s, 2H, D2O-exchangeable 
NH2), 7.77 (d, 2H, J = 9 Hz), 7.80 (d, 2H, J = 9 Hz), 10.63 (s, 1H, D2O-exchangeable NH). MS m/z (%): 
241 (M
+ + 2, 0.7), 240 (M
+ + 1, 5.8), 239 (M
+, 12.7), 238 (100), 222 (34.9), 172 (25.3), 159 (29.7),  
132 (19.1), 108 (47.3), 92 (46.3), 90 (25.1), 75 (15.9). Anal. Calcd for C9H9N3O3S (239.25): C, 45.18;  
H, 3.79; N, 17.56; S, 13.40. Found: C, 45.11; H, 3.70; 65, N, 17.42; S, 13.30%. 
3.2.2. N-[4-(Aminosulfonyl)phenyl]-3-aryl-2-cyanoacrylamide (5a–c) 
General Procedure: To a solution of cyanoacetanilide 3 (0.239 g, 1 mmol) and the appropriate 
aromatic aldhyeds (1 mmol) in dioxane (20 mL), was added few drops of piperidine and the reaction 
mixture was refluxed for 6 h. The solid product so formed was filtered off, washed with EtOH and then 
recrystallized from proper solvent to give 5a–c. 
3.2.3. 2-Cyano-3-phenyl-N-(4-sulfamoylphenyl)prop-2-enamide (5a) 
Yield (45%), mp 322 °C (from dioxane/ethanol); IR (KBr) νmax: 3362, 3316, 3262 (NH, NH2),  
2220 (C≡N), 1680 (C=O) cm
−1; 
1H-NMR (DMSO-d6):  δ 7.29 (s, 2H, D2O-exchangeable NH2),  
7.63 (d, 2H, J = 9 Hz), 7.80 (d, 2H, J = 9 Hz), 7.81–7.83 (m, 5H, ArH), 8.32 (s, 1H, olefinicH),  
10.70 (s, 1H, D2O-exchangeable NH). MS m/z (%): 327 (M
+, 18.2), 128 (40.4), 104 (10.7), 156 (100),  Int. J. Mol. Sci. 2014, 15 1245 
 
77 (23.9); Anal. Calcd for C16H13N3O3S (327.35): C, 58.70; H, 4.00; N, 12.84; S, 9.80. Found: C, 58.65; 
H, 3.88; N, 12.72; S, 9.77%. 
3.2.4. 2-Cyano-3-(4-methoxyphenyl)-N-(4-sulfamoylphenyl)prop-2-enamide (5b) 
Yield (90%), mp 292 °C (from dioxane/ethanol); IR (KBr) νmax: 3312, 3266, 3106 (NH, NH2),  
2218 (C≡N), 1682 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.87 (s, 3H, OCH3), 7.19 (d, 2H, J = 9 Hz), 7.27 
(s, 2H, D2O-exchangeable NH2), 7.82–7.83 (m, 4H, ArH), 8.04 (d, 2H, J = 9 Hz), 8.24 (s, 1H, olefinicH), 
10.56 (s, 1H, D2O-exchangeable NH); MS m/z (%): 357 (M
+, 11.3), 199 (0.3), 187 (12.6), 186 (100),  
158 (19.2), 77 (7.6); Anal. Calcd for C17H15N3O4S (357.38): C, 57.13; H, 4.23; N, 11.76; S, 8.97. 
Found: C, 57.00; H, 4.18; N, 11.55; S, 8.67%. 
3.2.5. 2-Cyano-3-(4-chlorophenyl)-N-(4-sulfamoylphenyl)prop-2-enamide (5c) 
Yield (63%), mp 286 °C (from dioxane/ethanol); IR (KBr) νmax: 3388, 3329, 3262 (NH, NH2), 2218 
(C≡N), 1688 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.37 (s, 2H, D2O-exchangeable NH2), 7.76 (d, 2H,  
J = 9 Hz), 7.91–8.07 (m, 4H, ArH), 8.10 (d, 2H, J = 9 Hz), 8.39 (s, 1H, olefinicH), 10.78 (s, 1H, 
D2O-exchangeable NH); MS m/z (%): 361 (M
+, 19.4), 191 (17.3), 190 (100), 162 (27.9), 127 (29.6),  
123 (4.6), 111 (5.8), 99 (5.2), 75 (13.8); Anal. Calcd for C16H12ClN3O3S (361.80): C, 53.11; H, 3.34;  
Cl, 9.80; N, 11.61; S, 8.86. Found: C, 53.01; H, 3.29; Cl, 9.72; N, 11.51; S, 8.76%. 
3.2.6. Synthesis of Pyridines 7a–c 
Method A: A mixture of 5 (10 mmol) and malononitrile (0.66 g, 10 mmol) in ethanol (30 mL) 
containing piperidine (0.5 mL) was heated under reflux for 3 h. After cooling, the precipitate was filtered 
off, washed with ethanol and then recrystallized from the proper solvent to give 7a–c. 
Method B: Equimolar amounts of 3 (10 mmol) and the appropriate 2-(arylidene)-malononitrile 
(namely 2-(benzylidene)-malononitrile, 2-(4-methoxybenzylidene)-malononitrile, and 2-(4-chloro 
benzylidene)-malononitrile) (10 mmol) in ethanol (30 mL) was treated with piperidine   
(0.5 mL) and the reaction mixture was heated under reflux for 3 h. After cooling, the precipitate was 
filtered off, washed with ethanol and then recrystallized from the proper solvent to give 7a–c. 
Method C: A mixture of 3 (10 mmol), the appropriate aldehyde (namely benzaldehyde, 
p-anisaldehyde, and p-chlorobenzaldehyde) (10 mmol), piperidine (10 mmol), and malononitrile   
(0.66 g, 10 mmol) in ethanol (30 mL) was heated under reflux for 3 h. After cooling, the precipitate was 
filtered off, washed with ethanol and then recrystallized from the proper solvent to give 7a–c. 
3.2.7. 4-(6-Amino-3,5-dicyano-2-oxo-4-phenylpyridin-1(2H)-yl)benzenesulfonamide (7a) 
Yield (54%), mp 316 °C (from dioxane/ethanol); IR (KBr) νmax: 3458, 3332, 3212 (NH, NH2), 2216 
(C≡N), 1672 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.50 (s, 2H, D2O-exchangeable NH2), 7.51–7.58  
(m, 7H, ArH, NH2), 7.60 (d, 2H, J = 9 Hz), 8.01 (d, 2H, J = 9 Hz); MS m/z (%): 392 (M
+ + 1, 10.7), 391 
(M
+, 7.8), 237 (7.8), 155 (9.2), 129 (8.7), 81 (46.5), 69 (100). Anal. Calcd for C19H13N5O3S (391.40):  
C, 58.30; H, 3.35; N, 17.89; S, 8.19. Found: C, 58.20; H, 3.34; N, 17.86; S, 8.15%. Int. J. Mol. Sci. 2014, 15 1246 
 
3.2.8. 4-[6-Amino-3,5-dicyano-4-(4-methoxyphenyl)-2-oxopyridin-1(2H)-yl]benzenesulfonamide (7b) 
Yield (56%), mp 350 °C (from dioxane/ethanol); IR (KBr) νmax: 3311, 3208, 3078 (NH, NH2), 2214 
(C≡N), 1659 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.88 (s, 3H, OCH3), 7.12 (s, 2H, D2O-exchangeable 
NH2), 7.50–7.52 (m, 6H, ArH, NH2), 7.62 (d, 2H, J = 9 Hz), 8.00 (d, 2H, J = 9 Hz); 
13C-NMR: δ 55.3, 
66.3, 75.4, 87.8, 114.0, 116.5, 120.1, 126.5, 127.7, 129.7, 132.7, 136.8, 145.3, 156.9, 159.5, 161.1;  
MS m/z (%): 422 (M
+ + 1, 15.1), 421 (M
+, 3.9), 336 (11.2), 265 (12.9), 229 (15.1), 195 (13.6), 185 
(34.8), 157 (22.6), 82 (34.4), 55.1 (100). Anal. Calcd for C20H15N5O4S (421.43): C, 57.00; H, 3.59;  
N, 16.62; S, 7.61. Found: C, 56.98; H, 3.53; N, 16.55; S, 7.58%. 
3.2.9. 4-[6-Amino-4-(4-chlorophenyl)-3,5-dicyano-2-oxopyridin-1(2H)-yl]benzenesulfonamide (7c) 
Yield (60%), mp > 300 °C (from dioxane/ethanol); IR (KBr) νmax: 3348, 3208, 3097 (NH, NH2), 2219 
(C≡N), 1661 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.51 (s, 2H, D2O-exchangeable NH2), 7.56–7.59  
(m, 4H, ArH), 7.69 (d, 2H, J = 9 Hz), 8.01 (d, 2H, J = 9 Hz), 8.10 (s, 2H, D2O-exchangeable NH2);  
MS m/z (%): 427 (M
+ + 2, 46.3), 426 (M
+ + 1, 46.0), 425 (M
+, 100), 397 (38.0), 313 (22.4), 269 (18.4), 
156 (25.8), 132 (28.2), 111 (27.3), 106 (22.4), 91 (41.4), 80 (29.1), 77 (55.2). Anal. Calcd for 
C19H12ClN5O3S (425.84): C, 53.59; H, 2.84; Cl, 8.33; N, 16.45; S, 7.53. Found: C, 53.46; H, 2.80;  
Cl, 8.30; N, 16.42; S, 7.50%. 
3.2.10. 4-(3-Cyano-4,6-dimethyl-2-oxopyridin-1(2H)-yl)benzenesulfonamide (10) 
To a mixture of cyanoacetanilide 3 (1.20 g, 5 mmol) and acetylacetone (0.50 g, 1mmol) in dioxane 
(20 mL), triethylamine (0.5 mL) was added and the reaction mixture was refluxed for 8 h. On cooling, 
the separated solid was filtered, washed with ethanol and crystallized from DMF to afford the 
corresponding 4-(3-cyano-4,6-dimethyl-2-oxopyridin-1(2H)-yl)benzenesulfonamide (10). Yield (64%), 
mp > 300 °C (from DMF); IR (KBr) νmax: 3314, 3174, 3083 (NH, NH2), 2223 (C≡N), 1648 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 1.98 (s, 3H, CH3), 2.40 (s, 3H, CH3), 6.49 (s, 1H, pyridineH), 7.52–7.57 (m, 4H, 
ArH, NH2), 7.99 (d, 2H, J = 9 Hz, ArH); MS m/z (%): 303 (M
+, 51.9), 302 (100), 274 (10.6), 223 (21.5), 
171 (0.9), 156 (2.8), 78 (23.6), 50 (20.6). Anal. Calcd for C14H13N3O3S (303.33): C, 55.43; H, 4.32;  
N, 13.85; S, 10.57. Found: C, 55.33; H, 4.28; N, 13.78; S, 10.52%. 
3.2.11. 2-Imino-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide (11) 
A mixture of equimolar amounts of 3 (1.20 g, 5 mmol) and salicyaldehyde (0.61 g, 5 mmol) in 
1,4-dioxane (25 mL) containing a catalytic amount of piperidine was heated under reflux for 2 h.  
The solid product formed was collected by filtration and recrystallized from dioxane/ethanol (3:1) to 
give  11. Yield (90%), mp 294 °C (from dioxane/ethanol); IR (KBr) νmax: 3318, 3244 (NH, NH2),  
1680 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.25 (s, 2H, D2O-exchangeable NH2), 7.32 (d, 2H, J = 9 Hz, 
ArH), 7.58–7.63 (m, 4H, ArH), 7.83 (d, 2H, J = 9 Hz, ArH), 8.58 (s, 1H, CH), 9.29 (s, 1H, 
D2O-exchangeable NH), 13.11 (s, 1H, D2O-exchangeable NH); MS m/z (%): 344 (M
+ + 1, 4.8), 343  
(M
+, 13.5), 172 (86.5), 156 (62.9), 143 (99.1), 65 (100). Anal. Calcd for C16H13N3O4S (343.35):   
C, 55.97; H, 3.82; N, 12.24; S, 9.34. Found: C, 55.90; H, 3.80; N, 12.20; S, 9.31%. Int. J. Mol. Sci. 2014, 15 1247 
 
3.2.12. 2-Oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide (12) 
Method A: To a solution of 3 (1.20 g, 5 mmol) in acetic acid (30 mL) containing 0.5 g of fused sodium 
acetate, salicyaldehyde (0.61 g, 5 mmol) was added. The mixture was heated under reflux for 2 h. After 
cooling, the formed product was collected by filtration and recrystallized from DMF to give 12. 
Method B: The iminochromene derivatives 11 (0.86 g, 2.5 mmol) was dissolved in boiling dioxane 
(40 mL) and treated with 5 mL HCl. The reaction mixture was heated under reflux for 2 h. Left to cool, 
the obtained product was filtered off, washed with cold water, and air-dried. Yield (86%), mp > 300 °C 
(from DMF); IR (KBr) νmax: 3362, 3258, 3108 (NH, NH2), 1698 (C=O) cm
−1; 
1H-NMR (DMSO-d6):  
δ 7.30 (s, 2H, D2O-exchangeable NH2), 7.57 (d, 2H, J = 9 Hz, ArH), 7.79–7.89 (m, 4H, ArH), 8.03  
(d, 2H, J = 9 Hz, ArH), 8.92 (s, 1H, CH), 10.88 (s, 1H, D2O-exchangeable NH); 
13C-NMR: δ 114.9, 
118.7, 119.8, 124.3, 126.9, 130.2, 134.6, 139.1, 141.2, 142.1, 153.5, 155.4, 160.2, 161.2; MS m/z (%): 
345 (M
+ + 1, 3.6), 344 (M
+, 10.1), 224 (2.8), 173 (100), 118 (5.8), 101 (47.3), 90 (14.6), 80 (14.2),  
76 (6.5), 64 (47.0). Anal. Calcd for C16H12N2O5S (344.34): C, 55.81; H, 3.51; N, 8.14; S, 9.31. Found: C, 
55.76; H, 3.45; N, 8.10; S, 9.29%. 
3.2.13. Coupling of N-[4-(Aminosulfonyl)phenyl]-2-cyanoacetamide (3) with the Appropriate 
Diazonium Salt of Aromatic Amines 
General procedure: To a cold solution of cyanoacetanilide 3 (1.20 g, 5 mmol) in pyridine (20 mL), 
was added the appropriate diazonium salt of aromatic amine (4-methylaniline or 4-methoxyaniline or 
aniline or 4-chloroaniline or methyl 2-aminobenzoate) (5 mmol) [prepared according to literature 
procedures] [32]. The addition was carried out portion wise with stirring at 0–5 °C over a period of  
30 min. After complete addition, the reaction mixture was stirred for a further 4 h then kept in an ice 
chest for 12 h and finally diluted with water. The precipitated solid was collected by filtration, washed 
with water, dried and finally recrystallized from the proper solvent to afford the corresponding coupling 
products 13a–e. 
3.2.14. 2-Cyano-2-[2-(4-methylphenyl)hydrazinylidene]-N-(4-sulfamoylphenyl)ethanamide (13a) 
Yield (94%), mp 288 °C (from dioxane); IR (KBr) νmax: 3325, 3226, 3186 (NH, NH2), 2214 
(C≡N),1664 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 2.30 (s, 3H, CH3), 7.20 (s, 2H, D2O-exchangeable 
NH2), 7.22–7.64 (m, 4H, ArH), 7.81 (d, 2H, J = 9 Hz, ArH), 7.92 (d, 2H, J = 9 Hz, ArH), 10.13 (s, 1H, 
D2O-exchangeable NH), 11.93 (s, 1H, D2O-exchangeable NH); MS m/z (%): 358 (M
+ + 1, 8.7),   
357 (M
+, 45.0), 198 (6.4), 186 (23.8), 172 (87.8), 134 (10.9), 119 (19.9), 106 (47.9), 91 (100), 77 (52.1), 
65 (38.3). Anal. Calcd for C16H15N5O3S (357.38): C, 53.77; H, 4.23; N, 19.60; S, 8.97. Found: C, 53.71; 
H, 4.20; N, 19.55; S, 8.87%. 
3.2.15. 2-Cyano-2-[2-(4-methoxyphenyl)hydrazinylidene]-N-(4-sulfamoylphenyl)ethanamide (13b) 
Yield (95%), mp 274 °C (from dioxane); IR (KBr) νmax: 3336, 3227 (NH, NH2), 2212 (C≡N),  
1662 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.77 (s, 3H, OCH3), 7.00 (d, 2H, J = 9 Hz, ArH), 7.25 (s, 2H, 
D2O-exchangeable NH2), 7.69 (d, 2H, J = 9 Hz, ArH), 7.81 (d, 2H, J = 8.7 Hz, ArH), 7.92 (d, 2H,  
J = 8.7 Hz, ArH), 10.10 (s, 1H, D2O-exchangeable NH), 11.95 (s, 1H, D2O-exchangeable NH);   Int. J. Mol. Sci. 2014, 15 1248 
 
MS m/z (%): 374 (M
+ + 1, 8.7), 373 (M
+, 24.3), 270 (5.8), 175 (21.4), 172 (39.8 ), 129 ( 22.3), 122 (100),  
107 (38.8), 92 (38.8), 77 (47.6). Anal. Calcd for C16H15N5O4S (373.38): C, 51.47; H, 4.05; N, 18.76;  
S, 8.59. Found: C, 51.36; H, 4.00; N, 18.69; S, 8.52%. 
3.2.16. 2-Cyano-2-(2-phenylhydrazinylidene)-N-(4-sulfamoylphenyl)ethanamide (13c) 
Yield (92%), mp > 300 °C (from dioxane); IR (KBr) νmax: 3367, 3269, 3240 (NH, NH2), 2218 (C≡N), 
1680 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.26 (s, 2H, D2O-exchangeable NH2), 7.38–7.79 (m, 5H, 
ArH), 7.82 (d, 2H, J = 9 Hz, ArH), 7.93 (d, 2H, J = 9 Hz, ArH), 10.17 (s, 1H, D2O-exchangeable NH), 
11.98 (s, 1H, D2O-exchangeable NH); MS m/z (%): 343 (M
+, 36.8), 206 (21.1), 198 (18.4), 172 (68.4), 
145 (50.0), 118 (31.6), 108 (36.8), 91 (84.2), 80 (50.0), 77 (76.3), 60 (100). Anal. Calcd for 
C15H13N5O3S (343.36): C, 52.47; H, 3.82; N, 20.40; S, 9.34. Found: C, C, 52.45; H, 3.78; N, 20.38;  
S, 9.30%. 
3.2.17. 2-[2-(4-Chlorophenyl)hydrazinylidene]-2-cyano-N-(4-sulfamoylphenyl)ethanamide (13d) 
Yield (95%), mp > 300 °C (from dioxane); IR (KBr) νmax: 3360, 3232, 3190 (NH, NH2), 2216 (C≡N), 
1668 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 7.26 (s, 2H, D2O-exchangeable NH2), 7.47 (d, 2H, J = 9 Hz), 
7.74–7.82 (m, 4H, ArH), 7.92 (d, 2H, J = 9 Hz), 10.22 (s, 1H, D2O-exchangeable NH), 12.04 (s, 1H, 
D2O-exchangeable NH); MS m/z (%): 379 (M
+ + 2, 17.9), 378 (M
+ + 1, 12.5), 377 (M
+, 39.3),   
296 (26.8), 238 (12.5 ), 206 (41.1), 182 (32.1), 172 (96.4), 156 (51.8), 125 (57.1), 111 (53.6), 106 (30.4), 
90 (69.6), 77 (21.4), 64 (100). Anal. Calcd for C15H12ClN5O3S (377.80): C, 47.69; H, 3.20; Cl, 9.38;  
N, 18.54; S, 8.49. Found: C, 47.61; H, 3.15; Cl, 9.27; N, 18.49; S, 8.43%. 
3.2.18. Methyl 4-[2-(1-Cyano-2-oxo-2-{(4-sulfamoylphenyl)amino}ethylidene)hydrazinyl]benzoate (13e) 
Yield (95%), mp > 300 °C (from dioxane); IR (KBr) νmax: 3340, 3231, 3148 (NH, NH2) 2211 (C≡N), 
1687 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.94 (s, 3H, CH3), 7.24 (s, 2H, D2O-exchangeable NH2), 
7.31–7.94 (m, 4H, ArH), 8.03 (d, 2H, J = 9 Hz), 8.32 (d, 2H, J = 9 Hz), 10.43 (s, 1H, D2O-exchangeable 
NH), 12.49 (s, 1H, D2O-exchangeable NH); MS m/z (%): 402 (M
+ + 1, 3.0), 401 (M
+, 12.8), 170 (11.7), 
133 (100), 90 (34.1), 92 (20.2), 77 (21.2), 65 (12.7). Anal. Calcd for C17H15N5O5S (401.39): C, 50.87;  
H, 3.77; N, 17.45; S, 7.99. Found: C, 50.81; H, 3.65; N, 17.40; S, 7.92%. 
3.2.19. Synthesis of Aminopyrazoles 14a,b 
To a solution of the compound 13a,b (5 mmol) in dioxane (20 mL), hydrazine hydrate (80%,  
1.0 mL, 5 mmol) was added and the reaction mixture was refluxed for 6 h and allowed to cool.  
The solid product obtained was filtered, washed with EtOH and dried. Recrystallization from dioxane 
afforded 14a,b. 
3.2.20. 4-({5-Amino-4-[(4-methylphenyl)diazenyl]-1H-pyrazol-3-yl}amino)benzenesulfonamide (14a) 
Yield (40%), mp 240 °C (from dioxane); IR (KBr) νmax: 3459, 3367, 3345, 3208 (NH, NH2), 2920, 
2859 (aliphaticCH) cm
−1; 
1H-NMR (DMSO-d6): δ 2.29 (s, 3H, CH3), 5.18 (s, 2H, D2O-exchangeable 
NH2), 7.23 (d, 2H, J = 9 Hz), 7.42 (d, 2H, J = 9 Hz), 7.49 (s, 2H, D2O-exchangeable NH2), 7.75–7.90  Int. J. Mol. Sci. 2014, 15 1249 
 
(m, 4H, ArH), 9.86 (s, 1H, D2O-exchangeable NH), 13.65 (s, 1H, D2O-exchangeable NH); 
13C-NMR:  
δ 20.5, 99.4, 117.0, 119.5, 126.4, 129.5, 132.9, 137.9, 141.8, 145.1, 151.5, 165.7; MS m/z (%):   
372 (M
+ + 1, 14.6), 356 (20.8), 217 ( 31.3 ), 201 (16.7), 156 ( 31.3 ), 126 ( 22.9), 123 (58.3), 107 (50.0), 
106 (100), 90 (50.0), 77 (54.2). Anal. Calcd for C16H17N7O2S (371.41): C, 51.74; H, 4.61; N, 26.40;  
S, 8.63. Found: C, 51.70; H, 4.58; N, 26.20; S, 8.59%. 
3.2.21. 4-({5-Amino-4-[(4-methoxyphenyl)diazenyl]-1H-pyrazol-3-yl}amino)benzenesulfonamide (14b) 
Yield (72%), mp 200 °C (from dioxane); IR (KBr) νmax: 3436, 3351, 3259 (NH, NH2),  
1658 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 3.77 (s, 3H, OCH3), 5.03 (s, 2H, D2O-exchangeable NH2), 
7.00 (d, 2H, J = 9 Hz), 7.21 (s, 2H, D2O-exchangeable NH2), 7.49 (d, 2H, J = 9 Hz), 7.77–7.81 (m, 4H, 
ArH), 9.70 (s, 1H, D2O-exchangeable NH), 13.20 (s, 1H, D2O-exchangeable NH); MS m/z (%):   
389 (M
+ + 2, 35.4), 388 (M
+ + 1, 40.2), 387 (M
+, 38.4), 250 (31.7 ), 216 (40.2), 196 (53.0 ), 171 (45.1), 
155 (31.7), 122 (33.5), 108 (34.8), 95 (40.2), 69 (100). Anal. Calcd for C16H17N7O3S (387.41): C, 49.60; 
H, 4.42; N, 25.31; S, 8.28. Found: C, 49.58; H, 4.40; N, 25.30; S, 8.20%. 
3.2.22. 4-Amino-3-phenyl-N-(4-sulfamoylphenyl)-2-thioxo-2,3-dihydro-1,3-thiazole-5-carboxamide (15) 
To a solution of cyanoacetamide 3 (1.20 g, 5 mmol) in DMF containing triethylamine (1 mL), 
elemental sulfur (0.16 g, 5 mmol) and phenyl isothiocyanate (0.68 mL, 5 mmol) were added. The 
reaction mixture was heated at 60 °C for 2 h with continous stirring and then poured into a beaker 
containing an ice-water mixture with few drops of HCl. The solid product so formed was filtered off, 
washed with EtOH and dried. Recrystallization from dioxane afforded compound 15. Yield (60%),  
mp > 300 °C (from DMF); IR (KBr) νmax: 3397, 3210 (NH, NH2), 1671 (C=O), 1335, 1217 (C=S) cm
−1; 
1H-NMR (DMSO-d6): δ 3.42 (s, 2H, D2O-exchangeable NH2), 7.19 (s, 2H, D2O-exchangeable NH2), 
7.50 (d, 2H, J = 9 Hz), 7.55–7.88 (m, 5H, ArH), 7.96 (d, 2H, J = 9 Hz), 8.45 (s, 1H, D2O-exchangeable 
NH); MS m/z (%) 406 (M
+, 0.9), 402 (5.7), 172 (14.3), 156 (8.6), 129 (11.4), 114 (11.4), 109 (17.1),  
82 (32.9), 76 (44.3), 63 (100). Anal. Calcd for C16H14N4O3S3 (406.50): C, 47.27; H, 3.47; N, 13.78;  
S, 23.66. Found: C, 47.21; H, 3.44; N, 13.71; S, 23.59%. 
3.2.23. 3,5-Diamino-4-cyano-N-(4-sulfamoylphenyl)thiophene-2-carboxamide (16) 
To a solution of compound 3 (1.20 g, 5 mmol) in dioxane (25 mL) containing triethylamine   
(1.00 mL), malononitrile (0.33 g, 5 mmol) was added followed by the addition of an equimolar amount 
of elemental sulfur (0.16 g, 5 mmol). The reaction mixture was heated under reflux for 5 h, then cooled 
and neutralized by pouring onto ice/water mixture containing few drops of hydrochloric acid. The solid 
product formed was collected by filtration and crystallized from dioxane. Yield (86%), mp > 300 °C 
(from dioxane); IR (KBr) νmax: 3743, 3316 (NH, NH2), 2209 (C≡N), 1635 (C=O) cm
−1; 
1H-NMR 
(DMSO-d6): δ 3.45 (s, 4H, D2O-exchangeable 2NH2), 7.26 (s, 2H, D2O-exchangeable NH2), 7.50–7.92 
(m, 4H, ArH), 11.36 (s, 1H, D2O-exchangeable NH); MS m/z (%): 338 (M
+ + 1, 44.9), 337 (M
+, 47.2), 
295 (47.2), 278 (45.7), 181 (49.6), 156 (53.5), 150 (51.9), 122 (51.2), 105 (64.6), 80 (48.8), 58 (100.0). 
Anal. Calcd for C12H11N5O3S (337.37): C, 42.72; H, 3.29; N, 20.76; S, 19.01. Found: C, 42.68; H, 3.21; 
N, 20.66; S, 18.96%. Int. J. Mol. Sci. 2014, 15 1250 
 
3.2.24. Synthesis of 18, 19 and 20 
Compound 3 (1.20 g, 5 mmol) was added to a stirred solution of potassium hydroxide (0.26 g,  
5 mmol) in DMF (20 mL). After stirring for 30 min, phenyl isothiocyanate (0.68 g, 5 mmol) was added 
to the resulting mixture. Stirring was continued for 6 h, and then chloroacetone or 3-(2-bromoacetyl)- 
2H-chromen-2-one or methyl iodide, (5 mmol) was added portion wise over a period of 30 min. After the 
addition was complete, the reaction mixture was stirred for an additional 12 h, during which the reactant 
dissolved and a yellow product precipitated. The solid product was filtered off, washed with EtOH and 
dried. Recrystallization from proper solvent afforded 18, 19 and 20. 
3.2.25. N-[4-(Aminosulfonyl)phenyl]-2-cyano-2-(4-methyl-3-phenyl-1,3-thiazol-2(3H)-ylidene)acet- 
amide (18) 
Yield (95%), mp 272 °C (from Dioxane) (lit. mp 260–262 °C) [31]; IR (KBr) νmax: 3294, 3196, 3107 
(NH, NH2), 2178 (C≡N), 1605 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 1.86 (s, 3H, CH3), 6.98 (s, 1H, 
thiazole-CH), 7.17 (s, 2H, D2O-exchangeable NH2), 7.49 (d, 2H, J = 9 Hz), 7.57 (d, 2H, J = 9 Hz), 
7.60–7.70 (m, 5H, ArH), 9.02 (s, 1H, D2O-exchangeable NH); 
13C-NMR (DMSO-d6): δ 14.2, 66.3, 
106.9, 115.9, 119.3, 126.2, 128.9, 129.6, 130.6, 136.6, 137.5, 138.3, 142.4, 165.1, 166.5; MS m/z (%): 
412 (M
+, 10.1), 332 (2.1), 241 (100), 214 (35.3), 198 (19.2), 172 (6.9), 118 (19.9), 90 (38.3), 77 (43.2). 
Anal. Calcd for C19H16N4O3S2 (412.48): C, 55.32; H, 3.91; N, 13.58; S, 15.55. Found: C, 55.30; H, 3.88; 
N, 13.51; S, 15.50%. 
3.2.26. 2-Cyano-2-[4-(2-oxo-2H-chromen-4-yl]-3-phenyl-1,3-thiazol-2(3H)-ylidene)-N-(4-sulfamoyl- 
phenyl)ethanamide (19) 
Yield (55%), mp 280 °C (from Dioxane); IR (KBr) νmax: 3367, 3310 and 3235 (NH, NH2), 3060 
(aromatic CH), 1713 (C=O), 1635 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 1.01 (s, 3H, J = 7.2 Hz, CH3), 
4.04 (q, 2H, J = 7.2 Hz, CH2), 7.08–7.13 (m, 5H, ArH), 7.21 (d, 2H, J = 9 Hz), 7.39–7.44 (m, 7H, ArH 
and NH2), 7.63 (d, 2H, J = 9 Hz), 9.54 (s, 1H, D2O-exchangeable NH), 9.73 (s, 1H, D2O-exchangeable 
NH); 
13C-NMR: δ 70.9, 95.3, 115.4, 115.8, 118.0, 119.6, 120.9, 124.8, 125.8, 126.3, 128.4, 128.8, 129.3, 
129.5, 132.7, 137.0, 138.0, 142.1, 143.0, 153.2, 158.4, 164.7, 171.3; MS m/z (%): 521 (M
+, 26.3),  
322 (15.8), 218 (100.0), 199 (15.8), 77 (86.0). Anal. Calcd for C27H18N4O5S2 (542.58): C, 59.77;  
H, 3.34; N, 10.33; S, 11.82. Found: C, 59.75; H, 3.30; N, 10.31; S, 11.79%. 
3.2.27. 2-Cyano-3-(methylsulfanyl)-3-(phenylamino)-N-(4-sulfamoylphenyl)prop-2-enamide (20) 
Yield (95%), mp 204 °C (from EtOH) (lit. mp 220–222 °C) [33]; IR (KBr) νmax: 3410, 3339, 3243, 
3119 (NH, NH2), 2194 (C≡N), 1628 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 2.49 (s, 3H, CH3), 7.18 (s, 2H, 
D2O-exchangeable NH2), 7.31–7.41 (m, 5H, ArH), 7.67 (d, 2H, J = 9 Hz), 7.79 (d, 2H, J = 9 Hz), 9.65  
(s, 1H, D2O-exchangeable NH), 9.91 (s, 1H, D2O-exchangeable NH); MS m/z (%): 389 (M
+ + 1, 63.0), 
388 (M
+, 10.9), 341 (58.7), 294 (100), 249 (56.5), 223 (67.4), 208 (68.5), 197 (58.7), 185 (25.0),  
182 (59.8), 140 (76.1), 92 (17.4). Anal. Calcd for C17H16N4O3S2 (388.46): C, 52.56; H, 4.15; N, 14.42;  
S, 16.51. Found: C, 52.50; H, 4.12; N, 14.45; S, 16.48%. Int. J. Mol. Sci. 2014, 15 1251 
 
3.2.28. 2-Cyano-2-(1,3-dithian-2-ylidene)-N-(4-sulfamoylphenyl)acetamide (22) 
To a stirred suspension of finely powdered potassium hydroxide (0.26 g, 5 mmole) in dry DMF  
(20 mL) cyanoacetamide 3 (1.20 g, 5 mmole) was added, the resulted mixture was cooled at 10 °C in an 
ice bath, then carbon disulfide (5 mmol) was added slowly over the course of 10 min. After addition was 
complete, stirring of the reaction mixture was continued for additional 2 h. Then dibromopropane  
(5 mmol) was added to the mixture while cooling (~15 °C) and stirring for 1 h. The mixture was then 
poured into crushed ice and the resulting precipitate was filtrated off, dried and crystallized from the 
proper solvent to give 22. Yield (95%), mp 278 °C (from Dioxane); IR (KBr) νmax: 3314, 3241, 3107 
(NH, NH2), 2209 (C≡N), 1653 (C=O) cm
−1; 
1H-NMR (DMSO-d6): δ 2.18 (m, 2H, J = 6.80 Hz, CH2), 
3.04 (t, 2H, J = 6.6 Hz, CH2), 3.19 (t, 2H, J = 6.6 Hz, CH2), 7.25 (s, 2H, D2O-exchangeable NH2),  
7.75 (m, 4H, ArH), 10.29 (s, 1H, D2O-exchangeable NH); 
13C-NMR: δ 22.5, 29.2, 98.5, 115.6, 119.8, 
126.5, 139.0, 141.3, 159.8, 177.3; MS m/z (%): 356 (M
+ + 1, 2.9), 355 (M
+, 14.8), 237 (0.2), 183 (100), 
129 (2.3), 118 (1.2), 110 (27.6), 80 (18.1). Anal. Calcd for C13H13N3O3S3 (355.45): C, 43.93; H, 3.69;  
N, 11.82; S, 27.06. Found: C, 43.85; H, 3.57; N, 11.78; S, 27.00%. 
3.3. Antimicrobial Evaluation 
The antibacterial and antifungal activity assays were carried out in the Medical Mycology Laboratory 
of the Regional Center for Mycology and Biotechnology of Al-Azhar University, Cairo, Egypt using the 
diffusion plate method [26–28] as follows: a bottomless cylinder containing a measured quantity   
(1 mL, 5 mg/mL) of the sample is placed on a plate (9 cm diameter) containing a solid bacterial medium 
(nutrient agar broth) or fungal medium, which has been heavily seeded with a spore suspension of the 
test organism. After incubation (24 h for bacteria and 5 days for fungi), the diameter of the clear zone of 
inhibition surrounding the sample is taken as measure of the inhibitory power of the sample against the 
particular test organism. The solvent used was DMSO and the concentration of the sample used is  
100 μg/mL. The results of antimicrobial activity are summarized in Table 1. 
4. Conclusions 
In conclusion, the reactivity of N-[4-(aminosulfonyl)phenyl]-2-cyanoacetamide (3) was investigated 
as a versatile and readily accessible building block for the synthesis of new heterocycles incorporating a 
sulfamoyl moiety of biological and pharmaceutical importance. 
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